Journal of the American Society of Nephrology
2008 JASN IMPACT FACTOR 7.505 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


Published ahead of print on February 25, 2009
J Am Soc Nephrol 20: 672-679, 2009
© 2009 American Society of Nephrology
doi: 10.1681/ASN.2008070669

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
ASN.2008070669v1
20/3/672    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Waikar, S. S.
Right arrow Articles by Bonventre, J. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Waikar, S. S.
Right arrow Articles by Bonventre, J. V.
Related Collections
Right arrowRelated Article

CLINICAL RESEARCH

Creatinine Kinetics and the Definition of Acute Kidney Injury

Sushrut S. Waikar and Joseph V. Bonventre

Renal Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts

Correspondence: Dr. Sushrut S. Waikar, Brigham and Women's Hospital, MRB-4, 75 Francis Street, Boston, MA 02115. Phone: 617-732-8474; Fax: 617-732-6392; E-mail: swaikar{at}partners.org

Received for publication July 2, 2008. Accepted for publication October 2, 2008.

Acute kidney injury (AKI) is a common and devastating medical condition, but no widely accepted definition exists. A recent classification system by the Acute Dialysis Quality Initiative (RIFLE) defines AKI largely by percentage increases in serum creatinine (SCr) over baseline. The Acute Kidney Injury Network defines the first stage by either an absolute or a percentage increase in SCr. To examine the implications of various definitions, we solved differential equations on the basis of mass balance principles. We simulated creatinine kinetics after AKI in the setting of normal baseline kidney function and stages 2, 3, and 4 chronic kidney disease (CKD). The percentage changes in SCr after severe AKI are highly dependent on baseline kidney function. Twenty-four hours after a 90% reduction in creatinine clearance, the rise in SCr was 246% with normal baseline kidney function, 174% in stage 2 CKD, 92% in stage 3 CKD, and only 47% in stage 4 CKD. By contrast, the absolute increase was nearly identical (1.8 to 2.0 mg/dl) across the spectrum of baseline kidney function. Time to reach a 50% increase in SCr was directly related to baseline kidney function: From 4 h (normal baseline) up to 27 h for stage 4 CKD. By contrast, the time to reach a 0.5-mg/dl increase in SCr was virtually identical after moderate to severe AKI (>50% reduction in creatinine clearance). We propose an alternative definition of AKI that incorporates absolute changes in SCr over a 24- to 48-h time period.


Related Article

This Month's Highlights
J. Am. Soc. Nephrol. 2009 20: A12. [Full Text] [PDF]



This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
P. J. Nelson and L. Cantley
GSK3{beta} Plays Dirty in Acute Kidney Injury
J. Am. Soc. Nephrol., February 1, 2010; 21(2): 199 - 200.
[Full Text] [PDF]


Home page
Ann Clin BiochemHome page
A. J P Lewington and A. Sayed
Acute kidney injury: how do we define it?
Ann Clin Biochem, January 1, 2010; 47(1): 4 - 7.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
Z. H. Endre and J. W. Pickering
Outcome definitions in non-dialysis intervention and prevention trials in acute kidney injury (AKI)
Nephrol. Dial. Transplant., January 1, 2010; 25(1): 107 - 118.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
S. S. Waikar, R. A. Betensky, and J. V. Bonventre
Creatinine as the gold standard for kidney injury biomarker studies?
Nephrol. Dial. Transplant., November 1, 2009; 24(11): 3263 - 3265.
[Full Text] [PDF]


Home page
CJASNHome page
J. W. Pickering, C. M. Frampton, and Z. H. Endre
Evaluation of Trial Outcomes in Acute Kidney Injury by Creatinine Modeling
Clin. J. Am. Soc. Nephrol., November 1, 2009; 4(11): 1705 - 1715.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP